top of page

Conclusions & Recommendations

TEC 24

24.9.1 - Overview of progress to date in the Americas region

2021

Heading 2

Americas

TEC recommends that ITI pursue discussions with PAHO to explore utilizing the Task Force for Global Health MOU with PAHO as an alternative mechanism for Zithromax® shipments to countries in the region.

Conclusion/Recommendation:

ITI and PAHO are currently in the process of drafting an agreement to facilitate this as of May 2022. This will be presented at TEC 27.

supply chain, recommendations for ITI management

TEC 24

24.8.1 - Tanzania

2021

Heading 2

Africa - East

TEC recognizes that TIS and TSS data in several districts are coming back above threshold more often than expected, which may point to ‘persistence’, may indicate lagging TF, or may be the result of population migration. TEC recommends that ITI work with Tropical Data to discuss appropriate methodologies for trachoma surveys among nomadic populations, consider assessing infection, and/or consider pursuing operational research on more-frequent-than-annual MDA with intensified surveillance to address this.

Tanzania

Conclusion/Recommendation:

This recommendation was shared with the program in September 2021 and a follow-up email was sent to Tropical Data (TD) regarding survey development. This was also discussed during the WHO Informal Consultation meeting in December 2021. This issue is being addressed by the country and implementing partners, who have conducted a deep dive to determine the factors around program implementation or epidemiology driving this observation. The findings of the deep dive will be presented at TEC 27.

persistence, research, recommendations for ITI management, alternative treatment strategies, special populations

TEC 24

24.7.5 - Ethiopia

2021

Heading 2

Africa - East

SNNP: TEC noted with concern that some historic MDAs may not have occurred as reported. TEC recommends that ITI follow up with the RHB, Sightsavers, and other partners to better understand these reports and take appropriate action.

Ethiopia

Conclusion/Recommendation:

ITI-Ethiopia followed up with Orbis to determine whether any past distributions have been incorrectly reported. It was reported by the implementing partner and the RHB that the data already in the database are accurate for those areas.

recommendations for ITI management

TEC 24

24.7.4 - Ethiopia

2021

Heading 2

Africa - East

Oromia: TEC recommends that ITI work with the Federal Ministry of Health, Regional Health Bureau, and the London School of Hygiene & Tropical Medicine study team to quantify the Zithromax® needs for the Stronger SAFE trial.

Ethiopia

Conclusion/Recommendation:

The research request has been incorporated in the 2023 Zithromax® Application.

research, recommendations for ITI management

TEC 24

24.7.3 - Ethiopia

2021

Heading 2

Africa - East

Beneshangul Gumuz (BG): TEC recommends that ITI work with the FMOH and the RHB to better understand the current situation in the Bambasi and Tongo camps, including the refugees’ origin and the type of camp (open vs. closed). This information may be submitted to the TEC refugee subcommittee and the algorithm applied to determine whether any further action is needed.

Ethiopia

Conclusion/Recommendation:

ITI-Ethiopia worked with the BG RHB to better understand the situation in the refugee camps and has determined the origin and type of camp. The details will be submitted to the refugee subcommittee to determine eligibility.

special populations

TEC 24

24.7.2 - Ethiopia

2021

Heading 2

Africa - East

Amhara: TEC recommends that ITI work with the Federal Ministry of Health (FMOH), Regional Health Bureau (RHB), and the University of California San Francisco (UCSF) study team to quantify the Zithromax® needs for the KETFO trial.

Ethiopia

Conclusion/Recommendation:

Zithromax® required for the KETFO study is included as a separate line in the 2023 Application.

research

TEC 24

24.7.1 - Ethiopia

2021

Heading 2

Africa - East

TEC noted with sadness the loss of Dr. Tebebe Yemane Berhan, a tireless advocate for the trachoma program in Ethiopia.

Ethiopia

Conclusion/Recommendation:

Condolences have been shared with the MOH and TCC.

TEC 24

24.6.3 - Sudan

2021

Heading 2

Eastern Mediterranean

TEC encourages partners to work with the MOH to identify what will be needed to prepare the program’s elimination dossier.

Sudan

Conclusion/Recommendation:

This recommendation has been shared with the MOH and partners.

end game

TEC 24

24.6.2 - Sudan

2021

Heading 2

Eastern Mediterranean

TEC also notes the trichiasis surgery needs in Sudan.

Sudan

Conclusion/Recommendation:

No action required

trichiasis

TEC 24

24.6.1 - Sudan

2021

Heading 2

Eastern Mediterranean

TEC notes with sadness the passing of Dr. Nabil, long-time Country Director for The Carter Center and former head of the Ministry of Health Guinea Worm Eradication Program in Sudan, whose support to the trachoma program was so vital to its progress over the years.

Sudan

Conclusion/Recommendation:

No action required

International Trachoma Initiative

330 West Ponce de Leon Avenue

Decatur, GA 30030 

Phone:

+1 800 765 7173
+1 404 371 0466
Fax:

+1 404 371 1087

  • Instagram
  • Facebook
  • Twitter
  • YouTube
bottom of page